Triton X-100, protease inhibitors, 50 mM NaCl) using a Amicon cell with 10 kDa cut-off. His-tagged α-ear and NECAP 1 were purified using Ni-NTA agarose and eluted with imidazole. For pull-down assays, 1 ml aliquots of brain extract or purified proteins in pull down buffer were incubated with GST fusion proteins or GST alone, precoupled to glutathione-Sepharose for 1 h at 4°C. For competition pull-down assays, 1 ml aliquots of brain extract were incubated with 200 pmol GST or GST NECAP 1 PHear domain precoupled to glutathione-Sepharose in the absence or presence of a synthetic amphiphysin I peptide at a range of molar ratios relative to the fusion protein as indicated on the figure. For immunoprecipitation studies, 1 ml aliquots of brain extract were incubated with 20 µl protein A-Sepharose beads and 20 µl of NECAP 1 or amphiphysin antibody or protein A-Sepharose beads alone (mock) for 3 h at 4°C. In all cases, the beads were subsequently washed with the appropiate buffer and specifically bound proteins were processed for SDS-PAGE and Western blotting.
Knock-down constructs and production of lentivirus. Control targeting sequences, D (scramble II: GCGCGCTTTGTAGGATTCG) and Q (TTCTCCGAACGTGTCACGT), designed by Dharmacon and
Qiagen, respectively, and targeting sequences designed for human NECAP 1 (N1nt170: ATATCAAACTCGAGGATAA, N1nt463: GGACAAACCATCAAGTTGT) and human NECAP 2 (N2nt266: GGTACTTCGTGATCCGCAT, N2nt332: ACCGAGGTGATGCCTTTGA) were used to generate shRNA expression constructs in pSIF1-H1-copGFP according to manufacturer's instructions (System Biosciences). For the NECAP sequences, the nucleotide positions (nt) given in the name correspond to the posistion of the first nucleotide of the targeting sequence in the human open reading frame. For virus production, 293-T were seeded with 10 7 cells/plate on 15 cm plates in 25 ml of regular culture medium (DMEM-high glucose (Gibco), 10% fetal bovine serum (Cansera), and 1% penicillin/streptomycin (Gibco)), with 5 plates for each virus. The following day, each shRNA expression construct was co-transfected with a packaging mix (containing pFIV-34N and pVSVG, System Biosciences) using calcium phosphate. Six hours post transfection, the medium was removed from each plate and replaced with 15 ml of collection medium per plate (regular medium supplemented with 1x nonessential amino acids (Gibco) and 1 mM sodium pyruvate (Gibco)). At 24, 36, and 48 hours post transfection, the medium was removed from each plate and for the 24 and 36 hour timepoint, replaced with 15 ml collection medium. The supernantants for each construct and each collection were combined and stored at 4°C until the end of the collection procedure. The supernatants were then filtered through a 0.45
µm PES membrane and stored in aliquots at -80°C. The virus was concentrated by centrifugation (2 hrs at 53,800 xg) and the resulting pellets were resuspended in DMEM in 1/2000 of the original volume.
Concentrated virus was stored at -80°C until use. To determine the virus titer, COS-7 cells were plated in 24 well plates with 40,000 cells/well in regular medium. At 12-14 hours post plating, the medium was replaced with 500 µl/well of transduction medium (DMEM supplemented with 2% fetal bovine serum, 1%
penicillin/streptomycin, and 6 µg/ml polybrene (Sigma)), containing varying amounts of concentrated virus. The next day, 1 ml regular medium was added to each well. Three days after transduction, the medium was replaced with 300 µl PBS to allow better visualization of the GFP fluorescence, and 
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